Pfizer Inc. (PFE): Big Things Are Happening at This Pharmaceutical Company

Page 1 of 2

Pharmaceutical company Pfizer Inc. (NYSE:PFE) has been doing some interesting things lately. The company has been shedding its non-pharmaceutical assets in order to focus on its core business which carries high profit margins. In April 2012, Pfizer sold its infant nutrition business to Nestle, and this February, the company spun off its animal health business Zoetis.

Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE)’s stock has fallen more than 10% from its high in April, pushing the dividend yield up to 3.45%. This increased yield, along with faster dividend growth than peers, makes Pfizer one of the best big-pharma dividend stocks out there.

A troubled past

Big pharmaceutical companies typically grow their dividends slowly, and Pfizer Inc. (NYSE:PFE) is no exception. From 2003 to 2012, Pfizer’s dividend grew at an annualized rate of just 4.3%, and in 2009, the company was forced to cut its dividend dramatically. The good news is that Pfizer has a far lower payout ratio with respect to the free cash flow than competitors like Merck & Co., Inc. (NYSE:MRK) and Eli Lilly & Co. (NYSE:LLY).

Company Payout ratio
Pfizer 42%
Merck 64%
Eli Lilly 51%

This allows Pfizer some room to grow the dividend, and at the end of last year, the company raised the dividend by 9%. But the big story here is the massive share repurchases which Pfizer Inc. (NYSE:PFE) has been doing.

Being aggressive

Pfizer has been using the cash generated from selling off its non-core assets to aggressively repurchase its shares. From 2011 through the first quarter of 2013, the company spent a total of $21.8 billion on share repurchases, reducing the share count by just about 10%. What’s more, the company still owns 80% of Zoetis, a position which it plans to unwind in short order. That’s nearly an additional $10 billion which can be used for share buybacks.

On top of that, the company generated over $15 billion in free cash flow in 2012, and after the dividend payment, that leaves about $9 billion which could be used for buybacks. Reducing the share count lowers the total dividend payment that the company has to make, thus lowering the payout ratio and creating more room for future dividend growth. And given that the stock trades at less than 13 times the free cash flow, the company is paying a reasonable price for its own shares.

Because the cash flow is so robust, Pfizer Inc. (NYSE:PFE) hasn’t needed to increase its debt in order to fund the buybacks. The company has a total of $40 billion in debt and an additional $11 billion in pension obligations, but cash and investments cover nearly all of that at $50.7 billion. Some companies take on huge amounts of debt to fund buybacks, which in general I don’t like, but Pfizer doesn’t have to.

Page 1 of 2
blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

The 10 Richest Stand Up Comedians in the World

The 10 Fattest Countries in the World

The 5 Best Summer Jobs for Teens

The 10 Most Religious Countries in the World Keeping the Faith

The 10 Most Educated Countries in the World

The 10 Most Popular Cell Phones in the World

The 10 Drunkest Countries in the World

The 10 Most Expensive Private Schools in the World

The 10 Smallest Countries in the World

Walking Dead Season 5 Spoilers You’ll Wish You Didn’t Know

The 10 Poorest Countries in the World

The 10 Greenest Countries in the World

The Top 10 Countries with the Highest Population in the World

The 10 Most Visited Countries in the World

The Top 10 Star Wars Characters in the Iconic Series

The 10 Most Expensive Android Phones in the World

5 Reasons Why The Illuminati Is Real and a Threat to Society

The 6 Scariest Halloween Costumes Ever Screamed At

The 4 Biggest Hedge Fund Managers in the World Today

The 15 Most Densely Populated Countries in the World

The 10 Biggest Tea Drinking Countries in the World

Top 6 Ways to Improve Your Checkout Process and Close Sales

The 5 Most Profitable Online Businesses You Can Start Today

The 20 Most Profitable Hospitals in the US

The 5 Most Profitable Home Businesses to Start

The 7 Teams that Will Win the Stanley Cup in 2015

The Top 10 Most Expensive Digital Cameras to Snap Stunning Shots With

The 10 Highest Quality Fast Food Restaurants In America Today

The 8 Best Halloween Decorating Ideas to Spook Up Your House

10 Marvel Women that Should Get a Movie Right Now

The 20 Best Remixes of Popular Songs that Will Make You Forget the Originals

7 Most Expensive Cities in the World

5 Least Expensive Cities in the World

10 Celebrities Who Believe In Scientology

10 High Margin Food Products to Build a Business Around

The 10 Most Expensive Clothing Stores in the United States to Get Decked Out At

The 5 Biggest Kickstarter Scams That Swindled Backers’ Donations

The 10 Most Expensive Boarding Schools In the World

50 Crazy Facts About Japan You Won’t Believe

Top 10 Least Expensive Hybrid Cars to Save the Planet With

The 10 Biggest ‘Gate’ Controversies in History

The 10 States with the Highest Nursing Shortages Leaving Their Hospitals Depleted

The 10 Best Value Investment Blogs that Every Investor Must Read

The 6 Cheapest Boarding Schools in Europe 2015

The 5 Most Expensive Cars To Insure in the World

The 10 Most Common Genetically Modified Foods

10 Self-Made Billionaires Who Came From Nothing

The 10 Most Expensive Cities to Live in North America

The 13 Most Expensive Headphones in the World to Represent

The Top 20 Wealthiest Soccer Teams in 2014

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!